Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2012-005291-34Phase 4Completed
A Phase 4 trial of liraglutide, human insulin in type 2 diabetes mellitus (T2DM), sponsored by AMC Health. Started Aug 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2012-005291-34.